Pharma Pulse 12/20/24: Trends in Enterprise Value Growth and ...
The latest news for pharma industry insiders.
Trade & Channel Strategies 2024: Trends in Enterprise Value Growth and Value-to-Sales Ratios
Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses observations in enterprise value growth and enterprise value-to-sales ratios among top biopharmaceutical companies.
Understanding PPF and Its Risk Factors
Anna-Maria Hoffmann-Vold, MD, PhD, discusses progressive pulmonary fibrosis, its primary causes and the key risk factors contributing to its development and progression.
Trump Says We'll Knock Out the Pharma 'Middleman'
Shares of pharmacy benefit managers extended losses Tuesday after Pfizer CEO Albert Bourla said President-elect Donald Trump is “very committed” to reforming drug-industry middlemen. Bloomberg's John Tozzi speaks with Sonali Basak on "Bloomberg Markets."
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement
EDO has released its Q3 2024 Diabetes Convergent TV Outcomes Report, providing critical insights into the diabetes category linear and streaming TV ad performance. The report reveals actionable findings on what drives consumer engagement in this category, with GLP-1 drugs reshaping the landscape of diabetes management and advertisers increasingly investing in convergent TV to target this growing audience.
Rust Felix on LinkedIn
As we step into 2025, the clinical trial landscape is poised for a seismic shift. In my latest piece for Pharmaceutical Executive, I dive into four critical trends reshaping our industry: heightened compliance demands, intensified focus on biospecimen data integrity, renewed emphasis on collaboration, and the rise of problematic lab technology solutions.
From the EU's early adoption of ICH E6(R3) guidelines to the rising importance of biospecimen lifecycle management, we're witnessing a paradigm shift in how trials are conducted. But with these challenges come unprecedented opportunities to innovate and streamline our processes. Are you ready to navigate this new terrain?
Discover how we can collectively transform clinical research, bringing life-changing therapies to patients faster than ever before. Read my full insights below and let's discuss how we can shape the future of clinical trials together.
#ClinicalTrials #BiospecimenManagement #PharmaTech #Innovation
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
